10 Best Biotech Stocks with Highest Upside Potential
On April 16, reports from J.P. Morgan's biopharma and medtech venture and licensing studies indicated that the capital markets began the year 2026 with selective strength.
Hedge Funds
News & Analysis
Top Fund Managers
Best Performing Funds
Featured Content
Insider Trading
News & Analysis
Latest Insider Purchases
Starks bought 10,000 Abbott Laboratories shares at $92.65
Heshmatpour bought 10,000 Neonc Technologies Holdings Inc. shares at $4.52
Handy bought 3,195 Washington Trust Bancorp Inc shares at $31.32
Ohsberg bought 1,606 Washington Trust Bancorp Inc shares at $31.00
Gray bought 4,556 Lamb Weston Holdings Inc. shares at $43.85
Latest Insider Sales
Raben sold 5,500 Bicara Therapeutics Inc. shares at $22.88
Kapito sold 187 Blackrock Inc. shares at $1,057.60
Kapito sold 5,364 Blackrock Inc. shares at $1,056.86
Kapito sold 3,188 Blackrock Inc. shares at $1,056.10
Gafke sold 152,529 Mitek Systems Inc shares at $13.92
Featured Content
Do not Miss

































